Does SIMVASTATIN Cause Ventricular septal defect? 79 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 79 reports of Ventricular septal defect have been filed in association with SIMVASTATIN (Simvastatin). This represents 0.3% of all adverse event reports for SIMVASTATIN.
79
Reports of Ventricular septal defect with SIMVASTATIN
0.3%
of all SIMVASTATIN reports
68
Deaths
0
Hospitalizations
How Dangerous Is Ventricular septal defect From SIMVASTATIN?
Of the 79 reports, 68 (86.1%) resulted in death.
Is Ventricular septal defect Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SIMVASTATIN. However, 79 reports have been filed with the FAERS database.
What Other Side Effects Does SIMVASTATIN Cause?
Myalgia (3,919)
Fatigue (2,066)
Arthralgia (1,775)
Drug interaction (1,744)
Nausea (1,676)
Rhabdomyolysis (1,616)
Dyspnoea (1,542)
Headache (1,470)
Drug hypersensitivity (1,433)
Muscular weakness (1,356)
What Other Drugs Cause Ventricular septal defect?
ONDANSETRON (301)
LAMOTRIGINE (238)
PAROXETINE (225)
SERTRALINE (193)
LEVETIRACETAM (172)
FLUOXETINE (171)
CITALOPRAM HYDROBROMIDE (158)
VENLAFAXINE (152)
ASPIRIN (146)
RAMIPRIL (145)
Which SIMVASTATIN Alternatives Have Lower Ventricular septal defect Risk?
SIMVASTATIN vs SINGULAIR
SIMVASTATIN vs SINTILIMAB
SIMVASTATIN vs SIPONIMOD
SIMVASTATIN vs SIPULEUCEL-T
SIMVASTATIN vs SIROLIMUS